Used in biomedical research to quantify levels of RAP1GAP protein in cell lysates or tissue samples, this ELISA kit enables investigation of RAP1 signaling pathways involved in cell adhesion, migration, and cancer progression. It is particularly valuable in oncology studies, where dysregulation of RAP1GAP has been linked to tumor growth and metastasis in cancers such as melanoma, breast, and liver cancer. Researchers use the kit to assess the impact of therapeutic agents on RAP1GAP expression and to explore its role as a potential tumor suppressor. The assay supports high-throughput screening and provides a reliable tool for monitoring protein changes in response to genetic or pharmacological interventions.